Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugen Proschak

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Kidney360|April 4, 2022
Multi-Target Drugs for Kidney DiseasesJohn D Imig, Daniel Merk, Eugen Proschak
GMS Infectious Diseases|January 24, 2019
Anti-tubercular activity of a natural stilbene and its synthetic derivativesClaudia Reinheimer, Dominik Büttner, Eugen Proschak, et al.
Plos One|June 8, 2011
Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitorsShirley K Knauer, Verena Fetz, Jens Rabenstein, et al.
European Journal of Pharmacology|March 10, 2015
Identification and characterisation of a prototype for a new class of competitive PPARγ antagonistsTilo Knape, Daniel Flesch, Laura Kuchler, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Kidney360|April 4, 2022
Multi-Target Drugs for Kidney DiseasesJohn D Imig, Daniel Merk, Eugen Proschak
GMS Infectious Diseases|January 24, 2019
Anti-tubercular activity of a natural stilbene and its synthetic derivativesClaudia Reinheimer, Dominik Büttner, Eugen Proschak, et al.
Plos One|June 8, 2011
Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitorsShirley K Knauer, Verena Fetz, Jens Rabenstein, et al.
European Journal of Pharmacology|March 10, 2015
Identification and characterisation of a prototype for a new class of competitive PPARγ antagonistsTilo Knape, Daniel Flesch, Laura Kuchler, et al.
Pageof 1